Cargando…

Clinical features and prognosis of triple-negative breast cancer

Detalles Bibliográficos
Autores principales:	Sanz, M Izquierdo, Maqueda, A Alsina, Riera, M Cabero, Xaurado, R Fabregas, Casas, F Tresserra, Gimferrer, M Cusido, Perez, C Ara, Hernandez, A Úbeda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284912/ http://dx.doi.org/10.1186/bcr2309

Ejemplares similares

Clinical features and prognosis of tubular breast cancer
por: Izquierdo Sanz, M, et al.
Publicado: (2011)

Malignant transformation of abdominal wall endometriosis with lymph node metastasis(): Case report and review of literature
por: Fargas Fàbregas, Francesc, et al.
Publicado: (2014)

The axillary study with ultrasound and cytological puncture with fine needle in invasive breast cancer.
por: Izquierdo, M, et al.
Publicado: (2005)

Breast sarcoma. A case report and review of literature
por: Li, Nuria, et al.
Publicado: (2016)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Therapy with Ulipristal Acetate in a Hypertensive Patient
por: Alcalde Dominguez, A., et al.
Publicado: (2018)

Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer
por: Bastiaansen, Anna E. M., et al.
Publicado: (2020)

T-cadherin is associated with prognosis in triple-negative breast cancer
por: Kong, De-Di, et al.
Publicado: (2017)

Triple-negative breast cancer: current treatment strategies and factors of negative prognosis
por: Baranova, Anna, et al.
Publicado: (2022)

Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis
por: Cserni, Gábor, et al.
Publicado: (2021)

Update on triple-negative breast cancer: prognosis and management strategies
por: Brouckaert, Olivier, et al.
Publicado: (2012)

Expression of RUNX1 Correlates with Poor Patient Prognosis in Triple Negative Breast Cancer
por: Ferrari, Nicola, et al.
Publicado: (2014)

Increased expression of MNK1b, the spliced isoform of MNK1, predicts poor prognosis and is associated with triple-negative breast cancer
por: Pinto-Díez, Celia, et al.
Publicado: (2018)

BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
por: Tanino, Hirokazu, et al.
Publicado: (2016)

Pre- and Post-Neoadjuvant Clinicopathological Parameters Can Help in the Prognosis and the Prediction of Response in HER2+ and Triple Negative Breast Cancer
por: Pons, Laura, et al.
Publicado: (2023)

The role of BRCA status on prognosis in patients with triple-negative breast cancer
por: Xie, Yuxin, et al.
Publicado: (2017)

Effects of BRCA Germline Mutations on Triple-Negative Breast Cancer Prognosis
por: Pogoda, Katarzyna, et al.
Publicado: (2020)

Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
por: Tischkowitz, Marc, et al.
Publicado: (2007)

CIP4 promotes metastasis in triple-negative breast cancer and is associated with poor patient prognosis
por: Cerqueira, Otto L.D., et al.
Publicado: (2015)

COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer
por: Ouyang, Mao, et al.
Publicado: (2015)

A CLDN1-Negative Phenotype Predicts Poor Prognosis in Triple-Negative Breast Cancer
por: Ma, Fei, et al.
Publicado: (2014)

Placental immune editing switch (PIES): learning about immunomodulatory pathways from a unique case report
por: Bronchud, Miguel H., et al.
Publicado: (2016)

Associations of Computed Tomography Image-Assessed Adiposity and Skeletal Muscles with Triple-Negative Breast Cancer
por: Aduse-Poku, Livingstone, et al.
Publicado: (2022)

CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer
por: Zhao, Zi-Ming, et al.
Publicado: (2019)

Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers
por: Lips, E H, et al.
Publicado: (2013)

Clinicopathologic features of triple negative breast cancers: an experience from Pakistan
por: Hashmi, Atif Ali, et al.
Publicado: (2014)

Triple negative breast cancer in North of Morocco: clinicopathologic and prognostic features
por: Derkaoui, Touria, et al.
Publicado: (2016)

Calcifications in triple-negative breast cancer: Molecular features and treatment strategies
por: Lin, Cai-Jin, et al.
Publicado: (2023)

Stratification of Prognosis of Triple-Negative Breast Cancer Patients Using Combinatorial Biomarkers
por: Yue, Yong, et al.
Publicado: (2016)

Prognosis in triple‐negative apocrine carcinomas of the breast: A population‐based study
por: Wu, Wenyu, et al.
Publicado: (2019)

Recent advances of transcriptomics and proteomics in triple‐negative breast cancer prognosis assessment
por: Li, Yuan, et al.
Publicado: (2022)

The Functional Impact of Alternative Splicing on the Survival Prognosis of Triple-Negative Breast Cancer
por: Wu, Sijia, et al.
Publicado: (2021)

Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancer
por: Pu, Shengyu, et al.
Publicado: (2022)

An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer
por: Zhang, Bo, et al.
Publicado: (2023)

Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer
por: Zhou, Qin, et al.
Publicado: (2023)

Genomic features of rapid versus late relapse in triple negative breast cancer
por: Zhang, Yiqing, et al.
Publicado: (2021)

Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy
por: López-Ozuna, Vanessa M., et al.
Publicado: (2016)

Identify the triple-negative and non-triple-negative breast cancer by using texture features of medicale ultrasonic image: A STROBE-compliant study
por: Chen, Qingyu, et al.
Publicado: (2021)

ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer
por: Daulat, Avais M., et al.
Publicado: (2019)

Nestin expression associates with poor prognosis and triple negative phenotype in locally advanced (T4) breast cancer
por: Piras, F., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_diulof9c4n6igoeb70g7kcqht8